CTSL and COVID-19: The quantifiable CTSL enzymatic activity has also been shown to be an additional factor in severecases of COVID-19, as well as being anindicator in numerous stages of cancer. Numerous inhibitors of CTSL enzymatic activity are known; its inhibition is one of the targets of thecommercial drug Paxlovid.